Mr. R Chicken,
In a nut shell,
Mo' than 75% of pregnant ladies who have R/A prior to conception, report dramatic reductions in R/A symptoms which continue till near 6 months after delivery.
The application of 2ME2 would reduce R/A symptoms but it might take mo' than a few weeks but maybe months. Capsules, with a lessor bioavailbilty then for Oncology, got the job done with a 99% efficacy rate in the rat population. It has worked well in the human population for the las' 10,000 years.
Mo' than 1/2 of those that have R/A will only see a Doctor once. The market is estimated at 18 >>>>> BILLION !
With our backs to the wall a bit one could surmise that it was time for some Magician to pull this Rabbit out o' the hat!
For those drugs that were approved and escaped Phase 3, the drug makers used a huge population for phase 2 , 200-300. Those numbers have been talked here.
Fargo thinks we have the bastards right where we want 'em, but frankly, I think he was drunk when he said it.
Best to alll,
vk 'n Fargo
Market Data 
Markets 
AI
